2018
Antenatal depression, psychotropic medication use, and inflammation among pregnant women
Miller E, Grobman W, Culhane J, Adam E, Buss C, Entringer S, Miller G, Wadhwa P, Keenan-Devlin L, Borders A. Antenatal depression, psychotropic medication use, and inflammation among pregnant women. Archives Of Women's Mental Health 2018, 21: 785-790. PMID: 29862416, PMCID: PMC6240365, DOI: 10.1007/s00737-018-0855-9.Peer-Reviewed Original ResearchConceptsAntenatal depressive symptomsInflammatory biomarkersPregnant womenProspective multicenter observational studyCross-sectional secondary analysisContext of pharmacotherapyHigher TNFα levelsMulticenter observational studyEpidemiologic Studies Depression ScalePsychotropic medication useLower TNFαPre-existing high levelsAntenatal depressionMedication useSerum TNFαTNFα levelsWeeks' gestationSelf-reported useDepression screenPsychotropic medicationsTNFα concentrationsMedical recordsPoor responseTherapeutic responseObservational study
2017
689: Does maternal inflammation mediate the relationship between antenatal depression and adverse pregnancy outcomes?
Miller E, Grobman W, Culhane J, Adam E, Buss C, Entringer S, Miller G, Simhan H, Wadhwa P, Williamson D, Kim K, Borders A. 689: Does maternal inflammation mediate the relationship between antenatal depression and adverse pregnancy outcomes? American Journal Of Obstetrics And Gynecology 2017, 216: s404. DOI: 10.1016/j.ajog.2016.11.423.Peer-Reviewed Original Research